Skip to content

The Rise of Private Credit as a Lucrative Asset Class and Attractive Lending Alternative

By Barbara Tague, Financial Research Leader

Private credit has soared in growth over the last decade, establishing itself as a lucrative asset class and attractive lending alternative to the broadly syndicated market.

Leveraging the AlphaSense platform, we surface intelligence and insights from leading analysts and industry experts to examine private credit’s trajectory and increasing institutional adoption.

AlphaCUT is your trusted source for the trends and intelligence making the most waves in today’s market. Download the report today to discover why experts believe private credit is “here to stay.”

About the Author
  • Barbara Tague, Financial Research Leader

    Barb is a Financial Research Leader covering the financial services segment at AlphaSense. Previously, she spent more than a decade at institutional investment managers and at a SaaS startup leading business development, content, and product initiatives.

Explore more

APAC Macro Briefing 2026: Risk Meets Opportunity

In this report, we show how resources and workflows available in the AlphaSense platform can help contextualize the APAC macro environment, exploring the key implications for corporate leaders and investors across sectors.
Title slide for "APAC Macro Briefing 2026: Risk Meets Opportunity" with a map of the Asia-Pacific region.

Top AI Use Cases for Private Equity

In this report, discover how private equity teams are leveraging AI to accelerate conviction with speed. With purpose built, AI-driven solutions like AlphaSense, teams are gaining a competitive advantage with custom workflows and unmatched content sets for the most differentiated deal intelligence.
Top AI Use Cases For Private Equity by Barb Tague, Financial Research Leader. Illustration featuring isometric buildings and currency symbols.

AI in Drug Development 2026: From Experimentation to Execution

Learn how AI is reshaping drug development in real time, turning AI execution into a key competitive differentiator.
Presentation slide titled "AI in Drug Development 2026: From Experimentation to Execution" by Sara Mallatt and Sean Carmichael, with line art of laboratory equipment.

Transform intelligence
into advantage

Develop bold strategies, seize opportunities,
and lead with clarity and confidence.